šŸ‡²šŸ‡¾ NPRA — PKKK/300/UP/021 Ā· PKKK/300/UP/011 Ā· PKKK/300/UP/014

ā—ˆ Seksyen Pengujian Produk & Kosmetik Ā· Unit Penyaringan

Steroid HPLC Screening Step-by-Step Guide

Complete Operational Workflow for Shimadzu Prominence-i (LabSolutions)

Comprehensive, execution-ready practical guide for screening 8 steroid adulterants (Dexamethasone, Betamethasone, Prednisone, Prednisolone, Triamcinolone acetonide, Hydrocortisone acetate, Cortisone acetate, Beta-17-valerate) in traditional medicines.

Instrument Shimadzu Prominence-i (LC-2030C 3D)
Column Kinetex Phenyl-Hexyl 100ƅ (150Ɨ4.6mm, 2.6µm)
Flow & Temp 0.7 mL/min @ 40°C
PDA Detection 240 nm (Scan 190–400 nm)
Extraction LLE with pH 7.0 adjustment
PHASE 1

Reagent Preparation & Standard Solutions

Ref: PKKK/300/UP/021 Para 6.1 & 6.4
PHASE 2

Liquid-Liquid Extraction (LLE) Protocol

Ref: PKKK/300/UP/014 Para 6.3 & PKKK/300/UP/021 Para 6.3
āš ļø CRITICAL REQUIREMENT: Per SOP 021 Para 6.3, the sample aqueous solution MUST BE ADJUSTED TO pH 7.0 before organic extraction.
PHASE 3

Shimadzu Prominence-i & LabSolutions Setup

Ref: PKKK/300/UP/011 & PKKK/300/UP/021 Table 1 & 2
PHASE 4

Real-Time Batch Sequence Table

Ref: PKKK/300/UP/021 Table 3 & Para 6.6

Load autosampler rack into Tray 1 and populate Real Time Batch table:

Vial / Row Sample / Standard Name Vial Type Inj Count Purpose / Rule
1Blank (Methanol : Water 1:1)Diluent1System equilibrium & baseline blank
2–7Mixed Working Standard (0.05 mg/mL)Standard6System Suitability Test (SST)
8–9Sample 1 (Duplicate: Inj 1 & Inj 2)Sample2Sample 1 Adulterant Screening
10Blank (Methanol : Water 1:1)Diluent1Carryover elimination
11–12Sample 2 (Duplicate: Inj 1 & Inj 2)Sample2Sample 2 Adulterant Screening
13Blank (Methanol : Water 1:1)Diluent1Carryover elimination
14–19Samples 3 to 5 (Duplicate each)Sample6Screening batch
20Mixed Working Standard (0.05 mg/mL)IQC Check1IQC Bracket (every 5 samples)
21Blank (Methanol : Water 1:1)Diluent1Wash
22–23Sample 6 (Duplicate)Sample2Subsequent samples
EndMixed Working Standard (0.05 mg/mL)End Std1Final Bracket Check
PHASE 5

Data Evaluation, SST Criteria & Confirmation Protocol

Ref: PKKK/300/UP/021 Para 6.6, 6.7, 6.8 & Borang UP/005
1. System Suitability Test (SST) Criteria (n = 6)
  • Retention Time %RSD: Must be ≤ 2.0% across all 6 replicate standard injections.
  • Peak Tailing Factor (T): T ≤ 2.0.
  • Theoretical Plates (N): N ≄ 2000.
  • Peak Resolution: All 8 steroid peaks must be well separated (except Betamethasone & Dexamethasone critical pair).
2. Internal Quality Control (IQC) Acceptance
  • Retention Time Drift: Percentage difference in retention time for mixed standard across the batch must be ≤ 3.0%.
3. Positive Identification Criteria (Sample Chromatogram vs Standard)

A steroid compound is declared POSITIVE (DIKESAN) if and only if:

  1. Retention Time Match: Retention time of sample peak matches the working standard peak within ±2%.
  2. UV Spectral Match: PDA UV absorption spectrum (190–400 nm) overlay shows a spectral similarity index > 0.999 compared to reference standard.
šŸ”’ MANDATORY 2ND ANALYST CONFIRMATION PROTOCOL (Para 6.8.2 – 6.8.4):
If a sample tests POSITIVE for any steroid:
  1. A Second Analyst must independently prepare a fresh sample extraction on a different date per `PKKK/300/UP/014` (adjusted to pH 7.0).
  2. The sample extract must be subjected to confirmatory analysis using GCMS (`PKKK/300/UP/004` Agilent 7890/5975C or `PKKK/300/UP/017` Agilent 8890/5977B) before issuing official failed report.
PHASE 6

Post-Analysis Column Wash & System Shutdown

Ref: PKKK/300/UP/011 Para 6.5